Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytek Biosciences Inc CTKB

Technology Scientific & Technical Instruments
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion... see more

Recent & Breaking News (NDAQ:CTKB)

Cytek Biosciences Reports Second Quarter 2023 Financial Results

GlobeNewswire August 8, 2023

Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023

GlobeNewswire July 20, 2023

Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference

GlobeNewswire May 31, 2023

Cytek Biosciences Announces $50 Million Stock Repurchase Program

GlobeNewswire May 19, 2023

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

GlobeNewswire May 16, 2023

Cytek Biosciences Reports First Quarter 2023 Financial Results

GlobeNewswire May 9, 2023

Cytek Biosciences Set to Join S&P SmallCap 600

PR Newswire April 25, 2023

Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023

GlobeNewswire April 20, 2023

Cytek® Biosciences Introduces New 20-Color AML Panel

GlobeNewswire March 7, 2023

Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire February 28, 2023

Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

GlobeNewswire February 28, 2023

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

GlobeNewswire February 13, 2023

Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

GlobeNewswire February 7, 2023

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

GlobeNewswire February 7, 2023

Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire February 6, 2023

Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference

GlobeNewswire November 21, 2022

Cytek® Biosciences Introduces Cytek Cloud

GlobeNewswire November 15, 2022

Cytek Biosciences Reports Third Quarter 2022 Financial Results

GlobeNewswire November 9, 2022

Cytek® Biosciences Names Chris Williams Chief Operating Officer

GlobeNewswire October 31, 2022

Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022

GlobeNewswire October 26, 2022